Now what
Fear was guiding investment decisions about coronavirus stocks on Monday, and as long as those alarming headlines spread across web pages and newspapers, that should continue. Perhaps investors are seeking shelter in certain defensive pharmaceutical titles, which might explain Pfizer's rise on the day. Either way, now is a nervy time to hold shares of biotechs active in the coronavirus fight.